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Abstract
Many neurodegenerative diseases, such as frontotemporal dementia (FTD), are associated with 
behavioral deficits, but the anatomical and molecular bases remain poorly understood. Here we 
show that forebrain-specific expression of FTD-associated mutant CHMP2B causes several age-
dependent neurodegenerative phenotypes, including social behavioral impairments. The social 
deficits were accompanied by a change in AMPA receptor (AMPAR) composition, leading to 
imbalance between Ca2+-permeable and -impermeable AMPARs. Expression of most AMPAR 
subunits was regulated by the brain-enriched microRNA (miR-124), whose abundance was 
markedly decreased in the superficial layers of cerebral cortex of FTD mice. We found similar 
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changes in miR-124 and AMPAR levels in the frontal cortex and iPSC-derived neurons of 
subjects with behavioral variant FTD. Moreover, miR-124 expression in the medial prefrontal 
cortex decreased AMPAR levels and partially rescued behavioral deficits. Knockdown of Gria2 
also alleviated social impairments in FTD mice. Our results identify a novel mechanism involving 
miR-124 and AMAPRs in regulating social behavior in FTD and suggest a potential therapeutic 
avenue.
Keywords
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Different neurodegenerative diseases are characterized by progressive dysfunction and loss 
of specific neuronal populations, often resulting in various behavioral abnormalities1-3. The 
molecular mechanisms of these impairments, and the neural circuits involved, are poorly 
understood. Frontotemporal dementia (FTD) is the second most common cause of dementia 
before 65 years of age. More than 50% of subjects with FTD have the behavioral variant, 
characterized by marked changes in personality and social behavior4. FTD has a strong 
genetic component; about 40% of subjects have a family history of the disease5. FTD is 
linked clinically, pathologically, and molecularly to amyotrophic lateral sclerosis6,7.
Mutations in several seemingly unrelated genes cause familial FTD6,7. However, the clinical 
outcome in subjects with FTD carrying different mutations is often similar, suggesting that 
the same neural circuits are affected. Mutations in charged multivesicular body protein 2B 
(CHMP2B) are especially interesting, as they are implicated not only in FTD and 
amyotrophic lateral sclerosis8,9 but also recently in early-onset Alzheimer’s disease10. 
CHMP2B encodes a component of the endosomal sorting complexes required for transport-
III (ESCRT-III), which functions in the endosomal-lysosomal and autophagy pathways11,12. 
The mutation that causes FTD results in a C-terminally truncated CHMP2B 
(CHMP2BIntron5)9 and a number of studies suggest a gain-of toxic function unique to the 
CHMP2BIntron5 isoform13-16.
Although the molecular basis of the social deficits associated with FTD is unknown, 
microRNAs (miRNAs), a class of small noncoding RNAs, are important contributors to 
neurodegeneration17,18. In that regard, miR-124 is an attractive candidate because it is 
evolutionary conserved and one of the most abundant miRNAs in the brain. Although 
miR-124 has well-established functions during neuronal development19, its specific roles in 
neurodegeneration are poorly understood17,18. Here, through a novel mouse model of FTD 
with the CHMP2BIntron5 mutation and studies on iPSC-derived human neurons and brain 
tissues of behavioral variant FTD (bvFTD), we uncovered unexpected contributions of 
miR-124 and AMPA receptors (AMPARs) to FTD-associated social impairments.
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RESULTS
A novel mouse model of FTD exhibits deficits in sociability
To examine the molecular basis of behavioral abnormalities in FTD, we generated a novel 
transgenic mouse model expressing, under the control of the tetracycline promoter, 
CHMP2BIntron5 (Fig. 1a). When crossed with a reporter line (TetO-GFP), CamkIIa-tTA 
drives GFP expression starting around E18 in forebrain neurons (Supplementary Fig. 1a). 
We then crossed CaMKIIa-tTA mice with different CHMP2BWT or CHMP2BIntron5 founder 
lines. Transgene expression pattern in tTA:CHMP2BWT and tTA:CHMP2BIntron5 mice was 
very similar to that of the reporter GFP (Supplementary Fig. 1b).
The extent of transgene expression was modest at both the mRNA level (Supplementary Fig. 
1c) and the protein level (Supplementary Fig. 1e) in tTA:CHMP2BWT and 
tTA:CHMP2BIntron5 mice. We selected tTA:CHMP2BWT line 3 and tTA:CHMP2BIntron5 line 
3 for further analysis in most experiments because of their equal transgene expression at the 
mRNA level (Supplementary Fig. 1c) and because CHMP2BIntron5 and CHMP2BWT 
proteins are equally stable15. Moreover, a doxycycline-containing diet repressed transgene 
transcription (Supplementary Fig. 1d).
To determine whether our mice have disease-relevant behavioral deficits, we first used the 
resident-intruder test20. Although tTA:CHMP2BIntron5 mice performed similarly to 
tTA:CHMP2BWT mice at the beginning of the test, their interaction times at the last two time 
points decreased (Supplementary Fig. 2a), suggesting specific defects in this social behavior. 
To further characterize the social behavioral deficits, we used a modified version of the 
three-chamber social paradigm21. In Trial 2, both tTA:CHMP2BWT and tTA:CHMP2BIntron5 
mice spent equally more time in the target chamber that contains Stranger 1 than in the 
empty chamber (Fig. 1b), indicating that CHMP2BIntron5 expression does not perturb the 
ability to recognize a conspecific mouse.
To quantify sociability, we measured the time test mice spent in close interaction with social 
partners across trials. In Trial 2, both tTA:CHMP2BWT and tTA:CHMP2BIntron5 mice 
showed equal sociability, which gradually decreased in later trials, suggesting progressive 
loss of social interest in the familiar mouse (Fig. 1c). However, tTA:CHMP2BIntron5 mice 
had a more pronounced, age-dependent decrease in sociability, particularly in Trial 5, when 
both social partners were present (Fig. 1c). We also observed a similar age-dependence in 
the elevated plus maze (Supplementary Fig. 2c). In Trial 5, the proportion of time 
tTA:CHMP2BIntron5 mice spent interacting with Stanger 2 was similar to that of 
tTA:CHMP2BWT mice, suggesting that they distinguished Stranger 1 from Stranger 2 
equally well (Fig. 1d). Moreover, time spent in each chamber during Trial 5 did not differ 
between tTA:CHMP2BIntron5 and tTA:CHMP2BWT mice (Fig. 1e), suggesting that social 
behavior but not exploration pattern is specifically compromised in mutant mice. Moreover, 
in a novel object recognition task in which exploration can be assessed independently of 
social cues, the times exploring identical objects during the familiarization phase as well as 
the familiar and novel object during the test phase were similar in tTA:CHMP2BIntron5 and 
tTA:CHMP2BWT mice (Supplementary Fig. 2d), confirming the specificity of the social 
deficits.
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The selective effect of CHMP2BIntron5 is also supported by the lack of major deficiency in 
locomotion (Supplementary Fig. 2e). Moreover, it is unlikely that the social deficits were 
due to perturbed olfaction, as we did not observe gross morphological defects in the 
olfactory bulb (Supplementary Fig. 3a,b). Moreover, tTA:CHMP2BIntron5 showed no 
differences from tTA:CHMP2BWT mice at 8 months of age in the time spent with either two 
supposedly preferred scents (cinnamon and vanilla) or an aversive scent (2-methyl butyrate) 
(Supplementary Fig. 2f), suggesting that their olfactory discrimination is not disrupted.
Thus, the FTD mice have a selective impairment in sociability. Moreover, seven of 36 old 
tTA:CHMP2BIntron5 mice (age 14-20 months) had cutaneous lesions compatible with 
excessive grooming, suggesting an obsessive-compulsive-like behavior (Supplementary Fig. 
2b). Together, these results indicate that expression of CHMP2BIntron5 in the mouse 
forebrain causes age-dependent behavioral deficits that recapitulate some of the clinical 
symptoms of bvFTD.
AMPAR composition is altered in the cortex of tTA:CHMP2BIntron5 mice
To investigate the cellular and molecular bases of the behavioral deficits, we found that at 8 
months of age, forebrain structures of tTA:CHMP2BIntron5 mice were similar to those of 
tTA:CHMP2BWT mice (Supplementary Fig. 3a,b) and showed no obvious neuronal loss 
(Supplementary Fig. 3c,d). However, tTA:CHMP2BInton5 mice had some FTD-like 
histopathological features, including astrogliosis, ubiquitin deposits, and an increase of p62 
in insoluble fraction (Supplementary Fig. 4a-d). In addition, in pyramidal neurons in the 
superficial layers (II and III) of the medial prefrontal cortex (mPFC)—which are most 
vulnerable in subjects with FTD22,23—spine number and density were greater in 
tTA:CHMP2BInton5 than in tTA:CHMP2BWT mice (Supplementary Fig. 3e,f). This increase 
was largely due to “thin” spines, which are considered immature24-26. We did not observe 
spine changes in hippocampal CA3 pyramidal neurons (Supplementary Fig. 3f), consistent 
with a greater susceptibility of certain neuronal populations in the mPFC.
To further examine synaptic defects, we first analyzed glutamate receptor levels and 
composition. qRT-PCR analysis of the various NMDA and kainate subunits showed no 
apparent differences between tTA:CHMP2BIntron5 and tTA:CHMP2BWTmice (Fig. 2a). 
However, in tTA:CHMP2BIntron5 mice, mRNAs encoding AMPAR subunits Gria2, Gria3, 
and Gria4 but not Gria1 were upregulated at 4 and 8 months of age (Fig. 2a), correlating 
with the age-dependent defects in sociability. Then we analyzed postsynaptic density (PSD) 
fractions from the cortex of tTA:CHMP2BIntron5 and tTA:CHMP2BWT mice. Interestingly, 
NMDA subunits and Gria1 were maintained at similar levels in tTA:CHMP2BIntron5 mice at 
all time points examined, whereas Gria2, Gria3, and Gria4 levels were increased 
substantially in mice aged 4 months and older (Fig. 2b and Supplementary Fig. 5a). 
Moreover, tTA:CHMP2BIntron5 mice at 8 months of age had a higher number of 
Gria2+PSD95+ (Fig. 2c) and Gria4+PSD95+ (Supplementary Fig. 5b) puncta in the mPFC, 
confirming the increased synaptic content of these subunits in situ. Thus, an age-dependent 
dysregulation of AMPAR subunit composition correlates with the onset of behavioral 
deficits in tTA:CHMP2BIntron5 mice.
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AMPAR function in the mPFC is altered in tTA:CHMP2BIntron5 mice
We next sought to link altered postsynaptic AMPARs to social defects in 
tTA:CHMP2BIntron5 mice. In 8-month old tTA:CHMP2BWT mice, intraperitoneal injection 
of NBQX (50 mg kg−1), a general AMPAR antagonist27, did not modify sociability (Fig. 
3a). In 8-month-old tTA:CHMP2BIntron5 mice, however, NBQX increased sociability, 
suggesting that an abnormal AMPAR activity might underlie the social defects in these mice 
(Fig. 3a). Injections of saline or the NMDA receptor antagonist AP5 (10 mg kg−1) did not 
affect sociability (data not shown) in either tTA:CHMP2BIntron5 or tTA:CHMP2BWT mice. 
Thus, these results, together with the changes in AMPAR composition in the cortex of 
tTA:CHMP2BIntron5 mice (Fig. 2), suggest that impaired social behaviors result from 
postsynaptic perturbation of synaptic AMPARs.
To further investigate AMPAR alterations at the functional level in FTD mice, we examined 
the electrophysiological properties of synapses in layers II and III made on apical dendrites 
of layer V pyramidal neurons in the mPFC in acute brain slices from 15-16-week-old mice. 
The amplitude or frequency of AMPAR-mediated miniature excitatory postsynaptic currents 
(AMPAR-mEPSCs) was not altered in tTA:CHMP2BIntron5 mice (Fig. 3b), suggesting that 
the presynaptic release mechanism or the overall synaptic strength of these neurons at the 
resting level was largely intact in the mutant mice.
Most AMPARs in principal excitatory neurons contain Gria2 and hence are Ca2+-
impermeable28. However, some AMPARs lack Gria229, causing these receptors to be Ca2+-
permeable and exhibit an inwardly rectifying current-voltage relationship due to voltage-
dependent blockade by intracellular polyamines30,31. Since Gria2 expression was increased 
in tTA:CHMP2BIntron5 mice (Fig. 2), one would expect a functional increase in the 
proportion of Gria2-containing AMPARs in mutant synapses. To test this hypothesis, we 
recorded AMPAR-mediated EPSCs in response to stimuli delivered to layer II and III at −60 
and +60 mV and calculated the rectification index, EPSC
−60mV/EPSC+60mV. Synapses of 
tTA:CHMP2BIntron5 mice had a lower rectification index than those of tTA:CHMP2BWT 
mice (Fig. 3c), suggesting an increased proportion of Gria2-containing receptors. Moreover, 
at a concentration of 200 μM, Naspm (a specific inhibitor of Ca2+-permeable AMPARs)32 
partially blocked AMPAR-mediated currents in tTA:CHMP2BWT neurons, indicating the 
existence of a substantial amount of AMPARs lacking Gria2 under control conditions. In 
contrast, EPSCs of tTA:CHMP2BIntron5 neurons were less sensitive to inhibition by Naspm 
(Fig. 3d), again indicating an altered AMPAR subunit composition characterized by an 
enrichment of Gria2-containing Ca2+-impermeable receptors. Thus, our data suggest that 
Gria2-lacking AMPARs exist in mPFC neurons of adult tTA:CHMP2BWT mice and that 
these native Ca2+-permeable receptors are replaced by Gria2-containing, Ca2+-impermeable 
AMPARs in tTA:CHMP2BIntron5 mice.
MiR-124 regulates AMPAR levels and is decreased in the cortex of tTA:CHMP2BIntron5 mice
We next examined mechanisms of the upregulation of AMPARs in tTA:CHMP2BIntron5 
mice. We turned our attention to miRNAs, as they control gene expression at the 
posttranscriptional level33 and are essential regulators of synaptic function34. Furthermore, 
each miRNA can regulate multiple mRNA targets that may contribute to complex processes, 
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such as sociability. We examined the expression levels of a number of brain-enriched 
miRNAs in the cortex in tTA:CHMP2BIntron5 mice at one month and at one year of age. At 
both time points, many miRNAs were expressed in the cortex at similar levels in 
tTA:CHMP2BIntron5 mice and tTA:CHMP2BWT mice (Supplementary Fig. 6b); however, at 
one year, some miRNAs were downregulated in tTA:CHMP2BIntron5 mice, especially 
miR-124, which is one of the most abundant miRNAs in the brain (Supplementary Fig. 
6a,b). miR-124 downregulation was specific to the expression of the FTD-causing 
CHMP2BIntron5, as these miRNAs remained unchanged in the cerebellum, where the 
transgene was not expressed (Supplementary Fig. 6a). Importantly, miR-124 was also 
downregulated to a lesser extent in the cortex of two other independent transgenic lines 
expressing lower level of CHMP2BIntron5 (Supplementary Fig. 6c). In contrast, variable 
levels of CHMP2BWT expression in the other mouse lines did not affect miR-124 abundance 
(Supplementary Fig. 6c). Moreover, when CHMP2BIntron5 expression was turned off in 
tTA:CHMP2BIntron5 mice fed a diet containing doxycycline (Supplementary Fig. 1d), their 
cortical miR-124 expression was identical to that in tTA:CHMP2BWT mice fed a regular diet 
or a diet containing doxycycline (Supplementary Fig. 7a). These results support a specific 
correlation between CHMP2BIntron5 expression and miR-124 reduction.
Computer algorithms (Targetscan, PicTar, miRanda) indicate that three AMPAR subunits, 
Gria2, Gria3, and Gria4, are potential targets of miR-124 (Fig. 4a). Thus, downregulation of 
miR-124 might contribute to the upregulation of these AMPARs in tTA:CHMP2BIntron5 
mice. Indeed, in transfected HEK293 cells, miR-124 markedly suppressed the expression of 
the reporter gene with the 3′UTRs of Gria2, Gria3, and Gria4 but not of Gria1 (Fig. 4b). 
Their expression was not suppressed when we mutated the miR-124 binding site (Fig. 4c). 
Similarly, in the cortex of tTA:CHMP2BIntron5 mice, miR-9 levels remained unchanged, 
whereas miR-124 was downregulated in an age-dependent manner (Fig. 4d,e), correlating 
with the age-dependent increase in Gria2, Gria3, and Gria4 levels (Fig. 2) and the social 
behavioral deficits (Fig. 1).
Consistent with previous studies35, miR-124 was widely expressed in all layers of the cortex 
of 2-month-old mice (Supplementary Fig. 7b). In contrast, miR-124 expression was 
markedly decreased in the cortex of tTA:CHMP2BIntron5 mice at 8 months of age, and this 
decrease seemed to be most pronounced in the layers II and III (Fig. 4f). Most neurons 
expressing miR-124 at low levels in the superficial layers were also strongly positive for 
CHMP2BIntron5 (Fig. 4g,h). Thus, expression of CHMP2BIntron5 triggers a progressive loss 
of miR-124 that is greater in superficial layers.
miR-124 and AMPARs are dysregulated in a subset of subjects with behavioral variant FTD
To confirm that our findings in mice are relevant to human disease, we next examined 
miR-124 and AMPAR levels in subjects with FTD. Since FTD is a heterogeneous disorder, 
we focused on the frontal cortex, a brain region critical for social behavior, in a subset of 
subjects with the behavioral variant (bvFTD), whose clinical presentation is closest to the 
phenotypes in our mice. In samples from two brain banks, we found a decrease in miR-124, 
but not miR-9, and a concomitant upregulation of GRIA2 and GRIA4 in the frontal cortex of 
five bvFTD cases compared with five age-matched controls (Fig. 5a).
Gascon et al. Page 6
Nat Med. Author manuscript; available in PMC 2015 June 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Then we took advantage of induced pluripotent stem cell lines derived from three subjects 
with bvFTD we established previously36,37. The levels of miR-124 and AMPARs in 2-
week-old neurons derived from four iPSC lines of three subjects with bvFTD were the same 
as those in controls (Fig. 5b). However, in 8-week old neurons of subjects with bvFTD, 
miR-124 was substantially reduced and some AMPAR subunit mRNAs were upregulated 
(Fig. 5c). This change is not due to culture condition since the percentages of different 
neuronal subtypes remained the same as those in cultures derived from controls 
(Supplementary Fig. 8a). As controls, the miR-9 level was not decreased (Fig. 5c) and we 
did not detect a change in NMDA or kainate receptor transcripts or neuronal subtype-
specific markers (Supplementary Fig. 8a,b).
To further confirm this finding, we surveyed published genome-wide studies of miRNAs on 
frontal cortex samples from subjects with FTD38. Re-analysis of the data showed a decrease 
in miR-124 level in the frontal cortex of subjects with progranulin deficiency (FTD-GRN) 
(Supplementary Fig. 9a). Another published study, of a small number of subjects, also 
showed a trend toward a decrease39. Similarly, re-analysis of a published transcriptome 
profiling data40 revealed an increase in some AMPAR subunits, but not of some NMDA 
receptor subunits, in the frontal cortex but not the cerebellum of six subjects with FTD-GRN 
(Supplementary Fig. 9b,c). These data are relevant to our study since most subjects with 
FTD-GRN belong to the behavioral variant41. Together, these findings suggest that 
dysregulation of miR-124 and AMPARs discovered in our mouse model also occurs in the 
frontal cortex in a subset of subjects with bvFTD.
MiR-124 expression and Gria2 knockdown in the mPFC partially rescue social deficits in 
tTA:CHMP2BIntron5 mice
To determine whether miR-124 downregulation contributes to FTD-associated social 
deficits in tTA:CHMP2BIntron5 mice, we engineered an adeno-associated vector (AAV) to 
express miR-124 in vitro (Supplementary Fig. 10a) and in vivo (Fig. 6a). The mPFC controls 
most social behaviors in mice42, and we detected synaptic defects in that region in 
tTA:CHMP2BIntron5 mice (Fig. 2). Therefore, we injected an AAV driving miR-124 
expression or a control AAV-GFP vector into the mPFC of 7-month-old mice.
We first observed that AAV-mediated miR-124 expression reduced mRNA levels of Gria2 
and Gria4 in the mPFC of tTA:CHMP2BIntron5 mice (Fig. 6b). The decrease was not due to 
the surgical procedure, since mRNA levels did not differ in the occipital cortex of the same 
mice (Supplementary Fig. 10b). Although we could not obtain enough material from these 
experiments for PSD fractionation, we did find a decrease in the number and the intensity of 
synaptic Gria2 puncta in brain sections (Fig. 6c). More importantly, AAV-GFP injection did 
not improve the sociability of tTA:CHMP2BIntron5 mice at either 1 or 2 months (Fig. 6d). In 
contrast, one month after injection of AAV-GFP-miR-124, the mice showed a substantial 
increase in sociability in Trial 5. These mice showed a further improvement at 2 months that 
was significantly better than the pre-injection level (P < 0.001), suggesting that the deficits 
were reversed (Fig. 6d). Finally, the time spent with Stranger 2 did not differ in AAV-GFP 
mice and those injected with AAV-GFP-miR-124 (Supplementary Fig. 10c), arguing for a 
role of miR-124 in specifically regulating sociability but not novelty recognition.
Gascon et al. Page 7
Nat Med. Author manuscript; available in PMC 2015 June 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
To further demonstrate that a decrease in Ca2+-impermeable AMPARs contributes to the 
social deficits in tTA:CHMP2BIntron5 mice, we constructed lentiviral vectors expressing 
scrambled short-hairpin RNA (shRNA) or shRNA directed against mouse Gria2 
(Supplementary Fig. 11a). After lentivirus injection into the mPFC of 7-month-old 
tTA:CHMP2BIntron5 mice, downregulation of Gria2 expression partially rescued the social 
deficits (Fig. 6e). Interestingly, recognition of the novel mouse (Stranger 2) during this trial 
was not affected (Supplementary Fig. 11b), suggesting that Gria2 levels are critical for 
sociability but not all aspects of social behavior. Together, these results support the notion 
that alterations in AMPARs composition in the mPFC contribute to social defects in 
tTA:CHMP2BIntron5 mice.
DISCUSSION
In a novel mouse model of FTD harboring the CHMP2BIntron5 mutation, we found that 
downregulation of miR-124 causes a dysregulation in AMPAR composition and a selective 
impairment in sociability. AAV-mediated ectopic expression of miR-124 in the mPFC 
partially restored the levels of AMPAR subunits and rescued the social behavioral deficits. 
Knockdown of Gria2 also alleviated the social deficits in FTD mice, suggesting a key role 
for Ca2+-impermeable AMPARs. Similar alterations in miR-124 and AMPAR levels were 
also found in human cortical neurons derived from iPSCs of subjects with bvFTD and in the 
frontal cortex of a subset of subjects with bvFTD. Thus, the mechanisms uncovered in our 
mouse model of FTD may have general implications for understanding behavioral 
abnormalities in human subjects with the disease.
Marked changes in social behavior such as social withdrawal and obsessive-compulsive 
behaviors are common in subjects with bvFTD4,43. Social deficits similar to those in our 
tTA:CHMP2BIntron5 mice were also reported in progranulin happloinsufficient mice44, an 
independent FTD model. In addition, a number of FTD histopathological hallmarks were 
present in our mice and previously published mouse models14,44, suggesting that the 
anatomical and behavioral abnormalities in subjects with FTD can be reproduced in mice. 
Despite widespread forebrain expression of mutant CHMP2BIntron5 protein in our FTD 
mice, only sociability was impaired at an early age, indicating that specific circuits are 
particularly vulnerable. Consistent with this notion, neurons in some regions of the human 
prefrontal cortex are most susceptible in FTD45. Moreover, ectopic miR-124 expression or 
Gria2 knockdown in this cortical area partially rescued the social behavioral deficits.
Our findings suggest that AMPAR composition is regulated by miR-124 and altered in FTD 
mice. More importantly, we also found miR-124 downregulation and a concomitant increase 
in AMPARs levels in the frontal cortex and iPSC-derived cortical neurons from subjects 
with bvFTD. AMPARs have been implicated in social behaviors. For instance, Gria3 
knockout mice show increased aggression46. Modulating AMPAR activity in the mPFC can 
result in both upward and downward movement in the social hierarchy42. Our 
electrophysiological analysis suggested that FTD-related social behaviors are linked to an 
increase in Ca2+-impermeable AMPARs at excitatory synapses of PFC pyramidal neurons. 
These abnormally inserted receptors may interfere with synaptic Ca2+ signaling or impair 
synaptic efficacy and plasticity47, leading to structural alterations in dendritic spines and 
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behavioral deficits in social interaction. We speculate these molecular changes may also 
contribute to the early behavioral abnormalities in subjects with FTD as well.
MiRNAs are deregulated in many neurodegenerative disorders18. The exact molecular link 
between CHMP2BIntron5 mutation and miR-124 reduction remains to be elucidated. 
However, previous works implicated a role of ESCRTs in the miRNA pathway48,49, raising 
the possibility that CHMP2BIntron5 mutation could affect miR-124 stability. Only six of 91 
neurotransmitter receptor subunit mRNAs are predicted targets of miR-124, including three 
of four known AMPAR subunits (Supplementary Table 1). Thus, miR-124 may play a 
unique role in fine-tuning glutamate neurotransmission by controlling the expression and 
composition of AMPARs, consistent with the inverse correlation between miR-124 and 
Gria2 levels reported here and by others50. Moreover, our finding that ectopic expression of 
miR-124 or Gria2 knockdown partially rescues behavioral deficits in early stages of FTD 
may suggest a potentially beneficial therapeutic approach before neuronal cell loss becomes 
apparent and irreversible.
ONLINE METHODS
Mice
All procedures involving mice were approved by the University of Massachusetts Medical 
School Institutional Animal Care and Use Committee. We cloned CHMP2BWT and 
CHMP2BIntron5 into the NotI and SalI sites of pTRE-Tight-BI-ZsGreen1 mammalian 
expression vector (Clontech). We linearized pTRE-CHMP2BWT vector with BsrBI, and 
purified DNA for microinjection. Since no adequate restriction enzymes were present on the 
pTRE-CHMP2BIntron5 plasmid, we amplified the cassette by PCR (TRESacIIFwd 5′-
CCGCGGCCACCTGACGTCG GCAGT GAA-3′ and TREApaIRV 5′-
GGGCCCCGAGTCAGTGAGCGAGGAAGCTC-3′) and subcloned into pCR2.1 TOPO 
(Invitrogen). We linearized this construct with SacII and ApaI enzymes, and purified DNA 
for microinjection. For both CHMP2BWT and CHMP2BIntron5 constructs, ZsGreen coding 
sequence was lost after linearization. Injected eggs were transferred to female recipients, and 
F1 litters analyzed for transgene insertion by PCR with two specific sets of primers (forward 
primer: 5′-GCTCGTTTAGTGAACCGTCAG-3′; reverse primer: 5′-AGCTC 
GGGGCAGTGAAAA-3′ or forward primer 5′-ATGGCGTCCCTCTTCAAGAAGA 
AAAG-3′ and reverse primer 5′-GGGCCCCGAGTCAGTGAGCGAGGAAGCTC-3′).
We maintained germline-transmitting founders (three for CHMP2BWT and three for 
CHMP2BIntron5) as hemizygous lines by backcrossing to wildtype C57BL/6 mice. To drive 
transgene expression in the forebrain, we crossed CHMP2BWT and CHMP2BIntron5 
transgenic mice with CaMKIIα-tTA mice (Jackson Laboratory 003010). We used both male 
and female double-transgenic offspring for all experiments.
Behavioral tests
We conducted all experiments between 9 am and 5 pm. We housed mice under specific-
pathogen-free conditions in an animal facility with a regular 12-h light and dark cycle (light 
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on at 7:00 am) under constant conditions (21 ± 1 °C; 60% humidity). Food and water were 
supplied ad libitum.
We conducted all behavioral studies using both male and female mice and analyzed data 
blind to genotypes. For all tasks, each mouse was selected randomly and then tested on the 
same day. We tested the first cohort of mice for sociability in the three-chamber social 
approach task. 2 d after the social test, we tested subjects in the open field and, 2 d later, in 
the elevated plus maze. We used independent cohorts of mice at 8 months of age for the 
other tests; these mice were not subjected to any other task.
Open field
We tested general exploratory locomotion in a novel open-field environment in 15 min 
sessions in a 40 × 40 × 40 cm white Plexiglas arena. The mouse was placed in the center of 
the arena and allowed to freely move while being recorded by an overhead camera. We 
analyzed behavior with an automated tracking system (Ethovision software, Noldus). The 
total distance traversed in the arena and the time spent in the center vs. the perimeter were 
automatically calculated.
Elevated plus maze
The elevated plus maze (Med Associates) consisted of two open arms and two closed arms 
situated opposite each other and separated by a 6 cm square center platform. Each runway is 
6 cm wide × 35 cm long. The open arms have lips 0.5 cm high to prevent mice from slipping 
off the arm, and the closed arms are surrounded on three sides by 20 cm high walls. The 
floors and walls are black polypropylene. For each test, the mouse was placed in the center 
square facing the open arms and allowed to explore freely for 5 min. The number of entries 
in the open and closed arms and the times spent in the open arms, closed arms, and the 
center square were quantified by automated analysis of beam breaks.
Three-chamber social task
We evaluated sociability, social recognition, and response to social novelty by using the 
three-chamber task with minor modifications. Test mice were housed individually for 1 
week before the test. We habituated the mice in the testing room for at least 1 min before the 
start of behavioral tasks. The social test apparatus consisted of a white Plexiglas box with 
removable floor and partitions dividing the box into three chambers with 5 cm openings 
between chambers. Target subjects (Stranger 1 and Stranger 2) were 10-14 week old males. 
We used wire cages to contain the stranger mice. We placed a paper cup on the top of the 
cage to prevent the test mice from climbing on the top of the wire cage. This task was 
carried out in five trials of 5 min each. After each trial, we returned the mouse to his home 
cage for 15 min.
• Trial 1: the test mouse is placed to the middle chamber and left to explore the arena 
containing the empty wire cages for 5 min (habituation).
• Trials 2–4: the mouse is placed in the middle chamber, but an unfamiliar mouse 
(Stranger 1) is placed into a wire cage in one of the side-chambers (the wire cage in 
the other side-chamber remains empty) (sociability, social learning acquisition).
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• Trial 5: a novel stranger mouse (Stranger 2) is placed in the previously empty wire 
cage and again the test mouse is left to explore for 5 min (sociability, social 
recognition memory).
We recorded and analyzed all the trials post hoc. We measured the time spent in each 
chamber and the time spent in close interaction with stranger mice for each trial. The 
following parameters were considered: (1) social recognition, defined as the ability to 
identify a conspecific (Stranger 1 versus the empty cage) in Trial 2 (spending more time in 
the side-chamber containing Stranger 1); (2) social novelty, defined as the ability to 
discriminate between a novel mouse (Stranger 2) and a familiar mouse (Stranger 1) in Trial 
5 (spending more time interacting with Stranger 2); and (3) sociability, which reflects the 
motivation of the test mouse to spontaneously interact with target mice in Trials 2-5.
Social interaction in home cage (resident-intruder test)
We assessed social interaction in the home cage by standard protocols52. Briefly, we housed 
individual test mouse for 1 week before the task. Then, they were habituated for 30 min to 
the test room. In this task, a mouse in his home cage is allowed to freely roam in the absence 
of the cage top for 1 min. A novel juvenile (4-week-old) male intruder is then placed in the 
opposite corner as the resident subject and allowed to roam freely for 5 min. The task is 
recorded, and total physical interaction between the two mice is quantified visually; social 
interaction is scored as the time during which the resident mouse actively explores the 
intruder. We did not observe fighting, biting, or attacking in this task.
Olfactory testing
After habituation to empty cages with no bedding, we tested mice for odor discrimination or 
sensitivity, as described53. In the discrimination task, mice are challenged with a filter paper 
embedded with an attractive scent (vanilla or cinnamon), an aversive scent (2-methyl 
butyrate), or a neutral scent (water). For the sensitivity task, dilutions of the same scent 
(vanilla) are used. The mice are videotaped, and the time spent sniffing the filter paper 
during a 3 min period is calculated post hoc.
Novel object recognition task
We performed the object recognition task as described54 following the no-habituation 
paradigm. The testing set-up was the same as for open field experiment. We placed mice in 
the testing room for at least 30 min for habituation. Then, mice were placed into the set-up 
containing two identical plastic sample objects (cube) placed 5 cm from one of the walls and 
~12 cm apart. The mice were allowed to explore the environment for 10 min, during which 
we recorded their movements. After this familiarization session, we cleaned the objects and 
open-field with 70% ethanol to eliminate any olfactory cues, and returned the mice to their 
home cage for 2 min. We then placed the mice again in the open field, but this time a novel 
object of similar size and complexity (cylinder instead of a cube) replaced one of the objects 
present during the familiarization session. The mice were allowed to explore the 
environment for 10 min (test session), after which we returned them to their cages. For both 
sessions, we placed mice into the open field, with the head positioned opposite the objects. 
Object exploration, defined as the duration of time in which the head of the mouse faced less 
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than 2 cm from the object, was measured during the first 5 min of each session. We 
calculated the recognition index as the percentage of time spent exploring the novel object 
versus the total time spent exploring the objects.
Drug injections
We diluted NBQX and AP5 (both from Tocris) in 0.9% saline solution and intraperitoneally 
injected them 10 min before the start of the test. Doses were 50 mg kg−1 for NBQX and 10 
mg kg−1 for AP5. We injected at least 10 mice per genotype with each drug, but each mouse 
received only a single injection. We quantified the total interaction time with both Stranger 1 
and Stranger 2 (Trial 5). To repress transgene expression, we fed mice with a diet containing 
doxycycline (200 mg kg−1) (Bioserv). To ensure early repression, we maintained breeder 
mice on a doxycycline-containing diet. After weaning and genotyping, we fed mice with this 
diet until 8 months of age.
Golgi staining
We processed mouse brains for morphological assessment with the FD Rapid Golgi Stain 
Kit (FD NeuroTechnologies) according to the manufacturer’s protocol. We submerged 
mouse brains in impregnation solution for 14 d and then flash frozen in isopentane at −70 
°C. Next, we cut 200 μm thick cryosections with a cryostat (Leica), mounted on gelatin-
coated slides, rinsed in dH2O, and incubated in developing solution for 10 min. Sections 
were dehydrated with increasing concentrations of ethanol, cleared with xylene, and 
coverslipped with Permount mounting medium.
We examined the slides with a Nikon inverted microscope at the imaging core facility 
(University of Massachusetts Medical School). We took image stacks of 40-120 μm 
segments of apical dendrites on pyramidal neurons of layer II-III of the mPFC or in the CA3 
region with a 100X oil-immersion lens (N.A. 1.45). For spine analysis, we quantified 15-25 
dendritic segments (n = 3 mice per genotype). Total dendritic length was 1897 μm for 
tTA:CHMP2BIntron5 mice and 1702 μm for tTA:CHMP2BWT mice. All image stacks were 
first deconvolved (with the iterative three-dimensional (3D) deconvolution plug-in for 
Image J) using a point-spread function (PSF) as a reference (PSF plug-in for ImageJ). We 
imported images into NeuronStudio for 3D analysis of spine density and spine size4 and 
measured spines in 3D from the z-stacks. We calculated the density by dividing the total 
number of spines per 100 μm of dendrite. A spine was labeled thin if its head was < 0.6 μm 
in diameter and had a maximum length of at least twice the head diameter. We classified a 
spine as mushroom if its head diameter was > 0.6 μm. Stubby spines were those lacking a 
neck. We classified other spines as “other”.
AAV production and injections
We constructed AAV particles (serotype 9) as described56. As a control, we use an AAV-
GFP vector so that no exogenous miRNA is expressed (limiting potentially off-target 
effects). We constructed AAV-GFP-miR-124 by inserting 500 bp of mouse pri-miR-124-1 
into the 3′UTR of the GFP cassette of the control vector. Lentivirus expressing short hairpin 
RNA (shRNA) were from the University of Massachusetts RNAi core facility, which houses 
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the complete collection of mouse lentiviral shRNA libraries from Open Biosystems57. We 
packed lentivirus particles as described58,59.
tTA:CHMP2BIntron5 and tTA:CHMP2BWT mice were deeply anesthetized with ketamine 
(100 mg kg−1) and xylazine (10 mg kg−1) and placed in a stereotaxic frame. The coordinates 
according to the mouse brain atlas of Paxinos & Franklin were: AP, 2.43 mm; ML, ± 0.28 
mm; DV, −1.81mm relative to the bregma, angled 14° toward the midline in the coronal 
plane. We injected high-titer vector (0.8-1.2 × 1013; 1.5 μl) bilaterally. At the end of the 
behavioral experiments, we sectioned the brains of these mice to verify the accuracy and 
extent of transduction. We analyzed the data from mice with correct injections in the target 
area. To calculate transduction efficiency, we stained brains from mice infected with AAVs 
or lentivirus (n = 6 per vector) with antibody against GFP before microscopic examination. 
For each mouse, we quantified the area transduced on four 20-μm-thick sections (bregma 
+2.2 to +1.9 mm) using Image J. The mean area of transduction per slice was 0.43 ± 0.095 
mm2 and 0.46 ± 0.087 mm2 for AAVs and lentivirus, respectively.
Electrophysiology
We conducted all experiments in accordance with the National Institutes of Health 
“Guidelines for the Care and Use of Laboratory Animals” and an approved animal protocol 
from the Harvard Medical Area Standing Committee on Animals.
We used tTA:CHMP2BWT and tTA:CHMP2BIntron5 mice at 15-16 weeks of age. The brains 
were rapidly removed and placed in ice-cold artificial CSF (ACSF) containing 126 mM 
NaCl, 2.5 mM KCl, 2.5 mM CaCl2, 1.2 mM MgCl2, 25 mM NaHCO3, 1.2 mM NaH2PO4, 
and 25 mM D-glucose. ACSF was saturated with 95% O2 and 5% CO2. We cut coronal 
cortical slices (300 μm) containing the mPFC with a Leica VT1200 Vibratome, and 
collected slices into a tissue incubator (Harvard Apparatus) and allowed them to recover for 
1 h in a 32 °C water bath. We then incubated slices in oxygenated ACSF for 1 h at room 
temperature (21-23 °C) and transferred to a recording chamber continuously perfused with 
oxygenated ACSF.
We did whole-cell voltage-clamp recordings of individual layer V pyramidal neurons using 
an Axoclamp 2B or a Multiclamp 700B amplifier (Molecular Devices) under infrared 
differential interference contrast microscopy. We identified pyramidal neurons by their 
morphology and delivered presynaptic stimuli (0.033 Hz, 200 μs) with a concentric bipolar 
electrode (FHC) placed at layer II and III of the mPFC cortex. For recordings of evoked 
EPSCs and miniature EPSCs (mEPSCs), neurons were voltage clamped at −60 mV unless 
indicated otherwise. We recorded evoked EPSCs every 30 s. The superfusion medium 
contained picrotoxin (100 μM) to block GABAA receptor-mediated synaptic responses. We 
added tetrodotoxin (1 μM, Sigma) and AP5 (2-amino-5-phosphonopentanoic acid, 50 μM, 
Abcam Biochemicals) during recordings of mEPSCs. We filled recording pipettes with 
solution containing 142 mM Cs-gluconate, 8 mM NaCl, 10 mM HEPES, 0.4 mM EGTA, 
2.5 mM QX-314 [N-(2,6-dimethylphenylcarbamoylmethyl)triethylammonium bromide], 2 
mM Mg-ATP, and 0.25 mM GTP-Tris, pH 7.25. For all recordings, temperature was 
maintained at 32°C with a temperature controller (Warner Instruments). For the Naspm (1-
naphthylacetyl spermine trihydrochloride) sensitivity assay, after stable EPSCs were 
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obtained for 10 min as baseline, we delivered the drug to the bath for 10-15 min with a 
gravity-driven perfusion system (Harvard Apparatus). We acquired data with a Digidata 
1440A and pClamp software (version 10.2; Molecular Devices). Signals were filtered at 1 
kHz, digitized at 10-20 kHz, and analyzed with Clampfit. We analyzed mEPSCs with Mini 
Analysis 6 (Synaptosoft).
In situ hybridization and immunofluorescence
Mice were deeply anesthetized with ketamine (100 mg kg−1) and xylazine (10 mg kg−1) and 
perfused intracardially with ice-cold PBS and then with 4% paraformaldehyde. Brains were 
extracted, postfixed in the same fixative overnight at 4 °C, transferred to a 30% sucrose 
solution for cryoprotection, frozen, and stored at −80 °C. We sectioned brain samples with a 
standard cryostat.
We used standard protocols for in situ hybridization and immunofluorescence60. For 
detection of miR-124, we purchased digoxigenin-labeled LNA probes from Exiqon. For 
transgene expression, a biotin- or digoxigenin-labeled RNA probe was synthesized with 
gene-specific PCR primers (forward 5′-
AAATAATACGACTCACTATAGGGAGATTCTTGATGA AATTGGAATTGAAAT-3′ 
and reverse 5′-GCAGTGAAAAAAATGCTTTATTTGT-3′) and cDNA templates from 
transgenic mouse brain. Probes were hybridized overnight at 55 °C, and the slides were 
incubated with horseradish peroxidase-conjugated antidigoxigenin antibody (Roche; 1:500) 
and steptavidin linked to the peroxidase (Roche). FITC or Cy3 TSA Plus kit (Perkin-Elmer) 
were used for final detection.
For immunofluorescence, we diluted primary antibodies in PBS containing 10% donkey 
serum (Sigma), 3% bovine albumin (Sigma), and 0.3% Triton X-100 and incubated 
overnight at 4 °C. Corresponding donkey anti-rabbit or anti-mouse Alexa 488 or 555 
(Invitrogen) was used for secondary detection. The primary antibodies were anti-NeuN 
(Milipore, MAB377 1:1,000), PSD95 (NeuroMab, 75-028; 1:5,000), GFAP (Dako, Z0334; 
1:2,000), Gria2 (Abcam, ab52932; 1:2,000), Gria4 (Abcam, ab77407; 1:1,000), ubiquitin 
(Enzo Life Sciences, BML-PW8810; 1;1000) and anti-GFP (Life Technologies, A11122; 
1:3,000).
Human brain samples
We obtained five FTD cases (3 men and 2 women, mean age at death 68 ± 6 years) and five 
age-matched normal controls (2 men and 3 women, mean age at death 79 ± 5 years) from 
the Mayo Clinic Jacksonville and the UCSF Neurodegenerative Disease Brain Bank. 
Informed consent was obtained for postmortem studies. Sex and postmortem interval (PMI) 
to autopsy were not different between cases and controls. FTD cases had sporadic 
behavioral variant FTD (bvFTD) due to FTLD-TDP, Type B. Control brains had no 
evidence of neurological disease either clinically or neuropathologically. We used frozen 
tissue (100-150 mg) from gray matter of the middle frontal gyrus for RNA extraction and 
subsequent RT-PCR analysis.
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Image acquisition and processing
For immunofluorescence and in situ hybridization, we acquired images with an Eclipse C1 
confocal microscope and software (Nikon). We quantified the number of NeuN neurons 
from fluorescence images of four tTA:CHMP2BWT mice and four tTA:CHMP2BIntron5 mice 
at 8 months of age; observers were blinded to genotype. For NeuN counting, we counted 
three to four sections of the mPFC with the Image J cell-counter plug-in.
For Gria puncta quantification, we used confocal z-stacks (159 × 159 × 10 μm). We 
analyzed three to four sections (n = 3 mice per genotype) or two sections (n = 6 mice per 
AAV vector). Following z-projection images, we quantified puncta using Particle Analyzer 
plug-in. We carried out GFAP coverage quantification as previously described14.
Northern blot
We extracted RNA from specific brain regions with Trizol reagent (Invitrogen) according to 
the manufacturer’s instructions. We loaded 5–10 μg total RNA into a urea-containing 12.5% 
acrylamide gel (Sequagel-Ureagel, National Diagnostics) and electrophoresed in standard 
TBE (1x) buffer. We then transferred RNA to a positively charged nylon membrane 
(Amersham) and hybridized overnight with digoxigenin-labeled LNA probes (Exiqon). We 
used anti-digoxigenin antibody linked to alkaline phosphatase (Roche, 11 093 274 910; 
1:10,000) and CDP-star reagent (Roche) for detection.
Western blot
We obtained cortical extracts61 and cortical PSD fractions21 as described. PSD or cortical 
samples (20 μg) were subjected to SDS-PAGE and probed with specific primary antibodies. 
After incubation with the appropriate secondary antibody linked to horseradish peroxidase 
(Jackson Immunoresearch), West Pico Signal Chemoluminescent Substrate (Thermo) was 
used for detection. Antibodies used in these experiments included rabbit antibodies against 
CHMP2B (Abcam, ab 33174; 1:2,000), Gria1 (Abcam, ab109450; 1:5,000), Gria2 (Abcam, 
ab52932; 1:2,000), Gria3 (Abcam, ab78366; 1:1,000), Gria4 (Abcam, ab77407; 1:1,000), 
Grin1 (Upstate Biotechnology, 05-4320; 1:1,000), Grin2a (Upstate Biotechnology, 07-632; 
1:2,000), Grin2b (Upstate Biotechnology, 0 -600; 1:1,000), p62 (Cell Signaling Technology, 
5114; 1:2,000), and β-actin (Sigma, A-5316; 1:10,000) as a loading control.
Luciferase assays
We cultured HEK cells in Dulbecco’s modified Eagle’s medium containing 10% fetal calf 
serum and split the day before transfection to achieve ~50% confluence at the time of 
transfection. We amplified 3′UTRs from Gria1, Gria2, Gria3, and Gria4 transcripts by PCR 
from mouse brain cDNA and cloned downstream from the renilla luciferase coding 
sequence of the psicheck2 vector (Promega). We obtained 3′UTRs containing mutated 
miR-124 binding sites (WT binding site GUGCCUA; mutated binding site GUCGAAAA) 
by PCR with specific primers including the mutated nucleotide sequence. We transfected 
cells with a plasmid containing an AMPAR subunit 3′UTR together with a vector driving 
the expression of miR-124 or miR-9 or an empty vector (pSuper, Oligoengine). For 
transfection, we used Fugene (Roche) according to the manufacturer’s instructions. After 24 
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h, we lysed the cells and measured luciferase activity with the Dual Luciferase Reporter 
Assay (Promega), and normalized results to firefly luciferase activity.
Quantitative RT-PCR
We extracted RNA with the miRNeasy kit (Qiagen) according to the manufacturer’s 
instructions and digested with DNase for 30 min on-column. We performed first-strand 
synthesis with 500 ng of total RNA, random hexamers, and TaqMan reverse transcription 
reagents (Applied Biosystems). Reactions without reverse transcription were always 
included.
For quantitative PCR, we designed and tested specific primers (Supplementary Table 2) at 
different cDNA dilutions, and calculated their efficiency. We only used primers showing 
95–105% efficiency for further analysis. We performed real-time quantitative PCR with a 
StepOnePlus system (Applied Biosystems). We carried out reactions (in triplicate) with 
SYBR Green PCR Master Mix (Applied Biosystems). Each SYBR Green reaction (total 
volume, 20 μl) contained 1 μl of cDNA as template and each primer at 0.25 μM. Controls 
without template DNA (reverse transcription minus reaction) were always negative. We 
incubated he reactions at 95 °C for 10 min to activate the HotStar Taq polymerase followed 
by 40 cycles at 95 °C for 15 s (denaturation) and at 60 °C for 1 min (annealing and 
extension). We used β-Actin or GADPH as internal control. Because SYBR Green 
indiscriminately binds to double-stranded DNA, other products in the PCR such as primer 
dimers may be detected along with the target gene. To verify that the SYBR Green dye 
detected only one PCR product, we subjected the samples to the heat dissociation protocol 
after the final cycle of PCR to check for the presence of only one peak.
Given the limited amount of human samples available, we used TaqMan miRNAs assays to 
quantify miRNA abundance in brain tissues and iPS-derived neurons (Applied Biosystems, 
assay 001182 for miR-124 and assay 000583 for miR-9). We extracted RNA as described 
for mouse samples. Then, we used specific primers for each miRNA for both reverse 
transcription and subsequent TaqMan quantitative PCR as specified by the manufacturer. 
We used U6 as internal reference gene for those experiments.
Mouse cortical cultures and iPSC-derived neuronal cultures
To test the efficiency of Gria2 shRNAs, we prepared neuronal cortical cultures from 
newborn mice as described10. 2 d after plating, 250 μl of lentiviral supernatant was added to 
the medium. We allowed cells to grow for 3 d and then lysed cells for protein extraction, and 
assessed Gria2 levels by western blot.
For iPSC-derived neuronal cultures, we used four different lines from three subjects with 
bvFTD. Two of these lines carry the progranulin S116X mutation36; the other two lines 
were derived from two subjects with bvFTD caused by C9ORF72 repeat expansion37. We 
used two iPSC lines from one healthy subject36 as controls and performed neuronal 
differentiation as described36,37.
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Statistical analysis
We performed all statistical analyses with Prism GraphPad 6.0. We compared 
tTA:CHMP2BWT and tTA:CHMP2BIntron5 mice for each behavioral task. We used the 
Student’s t test to detect genotype differences in electrophysiological experiments, qPCR, 
NeuN counting, biochemical analysis, and some behavioral tests. For shRNA efficiency, we 
used one-way ANOVA. We also used repeated-measure two-way ANOVA to detect 
differences in the AAV injections. We used Bonferroni’s or Fisher’s LSD test after ANOVA 
results and analyzed the results of antagonist injections with the Kruskal-Wallis test 
corrected for multiple comparisons. We used Mann-Whitney test for comparisons of brain 
human samples.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Age-dependent deficits in sociability in tTA:CHMP2BIntron5 mice. (a) Schematic 
representation of the wildtype and mutant CHMP2B proteins and the transgenic mouse 
strains used. (b) Social recognition, namely total time spent in the target chamber and empty 
chamber in Trial 2 at different ages, is measured in tTA:CHMP2BIntron5 mice (n = 11 mice 
per genotype, p > 0.6 by two-sided t test). (c) Sociability of tTA:CHMP2BWT and 
tTA:CHMP2BIntron5 mice are measured based on interaction time (n = 11 mice per 
genotype. **: P < 0.01 by two-sided t test). (d) Proportion of interaction time spent with 
Stranger 2 in Trial 5 was measured as an indicator for social memory and novelty in 
tTA:CHMP2BWT and tTA:CHMP2BIntron5 mice (n = 11 mice per genotype; P > 0.5 by two-
sided t test). All values are mean ± s.e.m. (e) Time spent in each chamber during Trial 5 was 
quantified as the exploration patterns (n = 11 mice per genotype; P > 0.5 by two-sided t 
test). All values are mean ± s.e.m.
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Figure 2. 
Biochemical characterization of glutamate receptor subunits in the cortex of 
tTA:CHMP2BIntron5 mice. (a) Quantitative RT-PCR analysis of mRNA levels of different 
glutamate receptor subunits (kainate, NMDA, and AMPA) in tTA:CHMP2BIntron5 and 
tTA:CHMP2BWT mice (n = 3 mice per genotype; *: P < 0.05, ***: P < 0.001 by two-sided t 
test). (b) Western blot analysis of the expression levels of AMPAR subunits in the PSD 
fractions of tTA:CHMP2BWT and tTA:CHMP2BIntron5 mice of different ages (n = 3 mice per 
genotype, *: P < 0.05, ***: P < 0.001 by two-sided t test). (c) Double-immunostaining 
analysis and quantification of PSD95-positive (green) and Gria2-positive (red) puncta in the 
mPFC (layers II and III) of 8-month-old mice (n = 3 mice per genotype, P < 0.02 by two-
sided t test). Scale bar, 200 μm. All values are mean ± s.e.m.
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Figure 3. 
Functional consequences of altered AMPAR composition in tTA:CHMP2BIntron5 mice. (a) 
Behavioral consequences of AMPAR inhibitor NBQX in tTA:CHMP2BWT and 
tTA:CHMP2BIntron5 mice at 8 months of age (n = 10 for all groups except n = 13 for 
tTA:CHMP2BWT saline; *: P < 0.05 by two-sided Kruskal-Wallis test corrected for multiple 
comparisons). (b) Whole-cell patch-clamp recordings of mEPSCs in pyramidal neurons in 
the mPFC. The amplitude and frequency of these miniature events were compared between 
tTA:CHMP2BWT mice (n = 11) and tTA:CHMP2BIntron5 mice (n = 12, P > 0.1 by two-sided 
t test). (c) The rectification index, calculated as EPSC
-60/EPSC+60, for AMPAR-mediated 
EPSCs, was measured (n = 10 for tTA:CHMP2BWT mice and n = 12 for tTA:CHMP2BIntron5 
mice; **: P < 0.01 by two-sided t test). (d) Decreased sensitivity of evoked EPSCs to 
Naspm (200 μM) inhibition in pyramidal neurons expressing CHMP2BIntron5. 
Representative EPSC traces at −60 mV before (Control) and after Naspm application are 
shown on the left (n = 8 mice for tTA:CHMP2BWT and n = 9 for tTA:CHMP2BIntron5. *: P < 
0.05 by two-sided t test). Mice used in b-d were 15-16 weeks of age. All values are mean ± 
s.e.m.
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Figure 4. 
MiR-124 targets AMPAR subunits, and its expression is reduced in the cortex of 
tTA:CHMP2BIntron5 mice. (a) Alignment of potential binding sites for miR-124 in the 
3′UTRs of Gria2, Gria3, and Gria4 mRNAs. (b) Direct interaction between 3′UTRs of 
Gria2, Gria3, and Gria4 mRNAs and miR-124 (n > 4 assays, *: P < 0.05, ***: P < 0.001 by 
two-sided t test). (c) The effects of miR-124 on the expression of luciferase-containing 
subunit 3′UTRs in which we mutated the miR-124 binding site. n = 4 assays, *: P < 0.05, 
**: P < 0.001 by two-sided t test. (d) Northern blot analysis of miR-9 and miR-124 
expression levels in the cortex of tTA:CHMP2BWT and tTA:CHMP2BIntron5 mice at different 
ages. (e) Quantification of the northern blots in panel d (n = 3 mice per group; *: P < 0.05, 
**: P < 0.01 by two-sided t test). (f) Fluorescence in situ hybridization of miR-124 in brain 
sections of tTA:CHMP2BWT and tTA:CHMP2BIntron5 mice at 8 months of age. (g) Double-
fluorescence in situ hybridization staining of miR-124 (red) in CHMP2BIntron5-expressing 
cells (green) in the cortex at 8 months of age. Scale bar, 150 μm in f and g. (h) Higher 
magnification of the boxed area in G. Scar bar, 20 μm. Values are mean ± s.e.m. in b and c 
and mean ± s.d. in e.
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Figure 5. 
miR-124 and AMPAR levels are altered in the frontal cortex of subjects with bvFTD and in 
cortical neurons derived from iPSC lines of three subjects with bvFTD. (a) Quantification of 
the abundance of miR-124, miR-9, and AMPAR transcripts by RT-PCR in the frontal cortex 
of subjects with bvFTD and controls. We normalized the content of AMPAR mRNAs 
against the geometric mean of four different neuronal-specific reference genes (MAP2, 
Enolase 2, GAP43, and PSD95). *: P < 0.05 by Mann-Whitney test. (b) Quantification of 
miR-124, miR-9, and AMPAR transcripts in 2-week old human neurons derived from 3 
iPSC lines of two control individuals and 4 iPSC lines from three subjects with bvFTD36,37. 
P > 0.1 by two-sided t test). (c) The levels of miR-124, miR-9, and AMPAR transcripts were 
measured again in these human neurons at 8 weeks (*: P < 0.05, **: P < 0.01, ***: P < 
0.001 by two-sided t test). All values are mean ± s.e.m.
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Figure 6. 
miR-124 expression and Gria2 knockdown in the mPFC partially rescue social deficits in 
tTA:CHMP2BIntron5 mice. (a) Double staining for GFP and miR-124 in tTA:CHMP2BIntron5 
mice (8 months) that received an intracranial injection of AAV-GFP (left panels) or AAV-
GFP-miR-124 (right panels). To facilitate assessment of differences in miR-124 levels, we 
took pictures at the periphery of the injection site so infected and noninfected cells are 
present in the same field. miR-124 levels were similar in AAV-GFP-infected cells and 
noninfected neighboring cells. In contrast, AAV-GFP-miR-124 induced a robust increase in 
miR-124 expression. (b) qRT-PCR analysis of Gria transcripts in the mPFC of 
tTA:CHMP2BIntron5 mice 2 months after AAV injection (n = 5 AAV-GFP-infected mice and 
n = 4 AAV-GFP-miR-124-infected mice; *: P < 0.05 by two-sided t test). (c) Quantification 
of the number of Gria2-positive puncta in tTA:CHMP2BIntron5 mice 2 months after 
intracranial injection of AAV-GFP or AAV-GFP-miR-124 (n = 3 mice per genotype, *: P < 
0.05 by two-sided t test). (d) Quantification of miR-124-dependent rescue of social deficits 
in tTA:CHMP2BIntron5 mice 1 and 2 months after bilateral injection. Sociability was 
significantly greater in mice injected with AAV-GFP-miR-124 in than in those injected with 
the control vector (n = 10 per AAV vector; *: P < 0.05, **: P < 0.01, ***: P < 0.001 by two-
sided repeated-measures two-way ANOVA corrected for multiple comparison, Bonferroni 
test). (e) Quantification of the rescue effects of in vivo downregulation of Gria2 expression 
on social deficits in tTA:CHMP2BIntron5 mice (n = 7 per group; *: P < 0.05, by two-sided 
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repeated-measures two-way ANOVA followed by Fisher’s LSD test). Scar bar, 20 μm. All 
values are mean ± s.e.m.
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